Table 1.
Body mass, lean mass, fat mass, total body water throughout the study period
Variable | Baseline | Supplementation (week) | |
---|---|---|---|
4 | 8 | ||
Body Mass (kg) | |||
Placebo | 81.60 ± 3.0 | 82.10 ± 3.04 | 82.30 ± 2.96 |
CIT-malate | 79.20 ± 2.50 | 79.50 ± 2.52 | 80.10 ± 2.42 |
GSH + CIT | 73.60 ± 1.74* | 74.60 ± 1.69 | 74.60 ± 1.73* |
Lean Mass (kg) | |||
Placebo | 59.92 ± 10.42 | 59.93 ± 10.33 | 59.81 ± 9.81 |
CIT-malate | 59.43 ± 8.47 | 59.59 ± 8.46 | 59.84 ± 7.93 |
GSH + CIT | 55.70 ± 7.28 | 56.46 ± 6.91* | 56.20 ± 6.93 |
Fat Mass (kg) | |||
Placebo | 13.10 ± 1.17 | 13.70 ± 1.19 | 14.00 ± 1.20 |
CIT-malate | 11.20 ± 1.04 | 11.50 ± 0.92 | 11.90 ± 0.96 |
GSH + CIT | 9.90 ± 0.71 | 10.30 ± 0.71 | 10.60 ± 0.69* |
Total Body Water (kg) | |||
Placebo | 48.20 ± 1.31 | 48.20 ± 1.32 | 48.40 ± 1.28 |
CIT-malate | 47.90 ± 1.14 | 48.10 ± 1.16 | 48.40 ± 1.14 |
GSH + CIT | 45.00 ± 0.89 | 45.50 ± 0.89 | 45.60 ± 0.89 |
Δ Lean Mass (kg) | |||
Placebo | 0.01 ± −0.09 | −0.11 ± 0.61 | |
CIT-malate | 0.16 ± − 0.01 | 0.41 ± − 0.54 | |
GSH + CIT | 0.76 ± − 0.37 | 0.5 ± − 0.35 | |
Δ Total Body Water (kg) | |||
Placebo | 0.0 ± 0.01 | 0.2 ± 0.03 | |
CIT-malate | 0.2 ± 0.02 | 0.3 ± 0.0 | |
GSH + CIT | 0.5 ± 0.0 | 0.6 ± 0.0 | |
Net Δ LM-TBW (kg) | |||
Placebo | 0.01 ± − 0.10 | −0.79 ± 0.58 | |
CIT-malate | 0.04 ± 0.08 | 0.11 ± − 0.54 | |
GSH + CIT | 0.26 ± 0.37 | 0.10 ± − 0.35 |
Mean ± SEM, *Significantly different from Placebo (p < 0.05), Δ = change from baseline, Net Δ = difference in the change in lean mass and total body water from baseline, LM lean mass, TBW total body water